Scinai Immunotherapeutics
SCNI
8 hedge funds and large institutions have $3.12M invested in Scinai Immunotherapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
27% less funds holding
Funds holding: 11 → 8 (-3)
30% less capital invested
Capital invested by funds: $4.43M → $3.12M (-$1.31M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$61.1K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$23K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$18.6K |
| 4 |
JP Morgan Chase
New York
|
+$1.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
-$525K |
| 2 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$232K |
| 3 |
II
Ibex Investors
Denver,
Colorado
|
-$15.9K |
| 4 |
Morgan Stanley
New York
|
-$4.43K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
II
1
Ibex Investors
Denver,
Colorado
| $2.75M | -$15.9K | -18 | -0.5% |
|
|
2
Renaissance Technologies
New York
| $163K | +$61.1K | +69 | +48% |
|
|
3
HighTower Advisors
Chicago,
Illinois
| $146K | +$18.6K | +21 | +13% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $27K | +$23K | +26 | +289% |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $19K | +$22.1K | +25 | New |
|
6
Wells Fargo
San Francisco,
California
| $7K | – | – | – |
|
|
7
Morgan Stanley
New York
| $2K | -$4.43K | -5 | -71% |
|
|
8
JP Morgan Chase
New York
| $1K | +$1.77K | +2 | New |
|
|
9
Mariner
Overland Park,
Kansas
| – | -$525K | -566 | Closed |
|
|
BHB
10
Bank Hapoalim BM
Tel Aviv,
Israel
| – | -$232K | -249 | Closed |
|
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -2 | Closed |
|
SCNI Hedge Fund Activity: Q1 2020 in Review
8 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Scinai Immunotherapeutics (SCNI) for Q1 2020, worth a combined $3.12M — down 30% from $4.43M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SCNI and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $61.1K. The largest seller was Mariner, exiting entirely with an estimated $525K sold.
- 8 institutional investors held Scinai Immunotherapeutics (SCNI) as of Q1 2020, down from 11 in Q4 2019.
- Funds reported $3.12M of Scinai Immunotherapeutics stock for Q1 2020, down 30% quarter-over-quarter.
- 2 funds opened new Scinai Immunotherapeutics positions in Q1 2020 and 3 closed out, a net change of -1 holder.
- The largest Scinai Immunotherapeutics buyer in Q1 2020 was Renaissance Technologies, an estimated $61.1K added.
- The largest Scinai Immunotherapeutics seller in Q1 2020 was Mariner, an estimated $525K sold.
Based on aggregated 13F filings for Q1 2020.